NV
NVCR
NovoCure Limited $15.51 1M -11.8% 3M -12.4% YTD +18.2% as of 2026-09-11↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset
▲ buy ▼ sell · size ≈ trade size · earnings ● beat ● miss · ring ◯ before open ◯ after close · ─ moving averages · click the buttons above to hide them
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.1%
Next 1 week
-0.8%
Next 1 month
-0.6%
Seasonality
Weak window historically
Next 30 days (to Oct 14): -9.2% median,
20% of the last 10 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 24
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is -0.05%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 1.60 -0.3% · Seasonal tilt (10y) -0.3%
$22M/day volume
80% volatility
+27% 1-year
52-week range · 49% of the way up · -28% from the high
$9.82$21.45
Congressional trades in NVCR Full tracker →
2 members · 2 buys / 1 sells · $17K–$80K disclosed · latest filing Aug 5, 2021.
| BUY | $15K–$50K | |
| BUY | $1K–$15K | |
| SELL | $1K–$15K |
Earnings Full history →
Next report 2026-10-29 (Thursday, before open, in 45 days) · EPS est. -0.24.
1-day std dev
11.5%
Finished up
44%
Biggest pop
+28.4%
Biggest drop
-29.3%
Standard deviation of the close-to-close move over the last 43 reports. History, not a forecast.
Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.